New Rhode Island lab to develop vaccines

Researchers at the newly formed Institute for Immunology and Informatics at the University of Rhode Island will focus on developing vaccines for diseases that are rampant in poor countries, including malaria, dengue fever, AIDS and tuberculosis, using a "genome-to-vaccine" approach. The institute will have access to the bioinformatics tools of biotech firm EpiVax in exchange for partial rights to potential disease-prevention discoveries.

View Full Article in:

Providence Journal (R.I.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN